Vancomycin MICs for Methicillin-Resistant Staphylococcus aureus Isolates Differ Based upon the Susceptibility Test Method Used
- 1 December 2008
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (12) , 4528
- https://doi.org/10.1128/aac.00904-08
Abstract
Recent studies have questioned treatment of serious methicillin-resistant Staphylococcus aureus (MRSA) infections with vancomycin because of treatment failures, despite vancomycin MICs in the susceptible category (MIC ≤ 2 μg/ml) ([2][1], [3][2], [5][3], [6][4], [7][5]). Some of these studies haveKeywords
This publication has 6 references indexed in Scilit:
- Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus BacteremiaClinical Infectious Diseases, 2008
- High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus InfectionsArchives of internal medicine (1960), 2006
- Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 μg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysisClinical Therapeutics, 2006
- Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin TherapyClinical Infectious Diseases, 2004
- Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus BacteremiaJournal of Clinical Microbiology, 2004
- Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract InfectionsClinical Pharmacokinetics, 2004